[Drug-induced rhabdomyolysis]

Nihon Rinsho. 2007 Oct 28:65 Suppl 8:567-71.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Anesthetics / adverse effects
  • Angiotensin II Type 1 Receptor Blockers / adverse effects
  • Anti-Infective Agents / adverse effects*
  • Anti-Ulcer Agents / adverse effects*
  • Antiparkinson Agents / adverse effects
  • Antipsychotic Agents / adverse effects
  • Glycyrrhizic Acid / adverse effects
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hypolipidemic Agents / adverse effects*
  • Immunosuppressive Agents / adverse effects
  • Malignant Hyperthermia / etiology
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / diagnosis
  • Rhabdomyolysis / prevention & control
  • Rhabdomyolysis / therapy
  • Time Factors

Substances

  • Anesthetics
  • Angiotensin II Type 1 Receptor Blockers
  • Anti-Infective Agents
  • Anti-Ulcer Agents
  • Antiparkinson Agents
  • Antipsychotic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Immunosuppressive Agents
  • Glycyrrhizic Acid